Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-25-013044

Options or other derivatives

  • EVP, Chief Financial Officer acquired 561,330 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Duarte Ira EVP, Chief Financial Officer 2025-01-31 Grant or award · Employee Stock Option (Right to Buy) +374,220 374,220 D
Duarte Ira EVP, Chief Financial Officer 2025-01-31 Grant or award · Restricted Stock Units +187,110 187,110 D
Loading xslF345X05/ownership.xml…